Simple Summary Glioblastoma (GBM) is one of the most malignant types of central nervous
system tumor which accounts for more than 60% of all brain tumors in adults. Owing to poor …

miRNA-148b belongs to the family miR-148/-152, with significant differences in nonseed
sequences, which can target diverse mRNA molecules. Reportedly, it may undergo …

There is no effective therapy for the lately increased incidence of glioblastoma multiforme
(GBM)—the most common primary brain tumor characterized by a high degree of …

Notorious for its high mortality rate, the current standard treatment for high-grade gliomas
remains a challenge. This is largely due to the complex heterogeneity of the tumour coupled …

Human glioblastoma multiforme (GBM) is a primary malignant brain tumor, a radically
incurable disease characterized by rapid growth resistance to classical therapies, with a …

Glioblastoma multiforme (GBM) is the most common type of glioma, with a median survival of
14.6 months post-diagnosis. Understanding the molecular profile of such tumors allowed the …

Glioblastoma Multiforme (GBM) is one of the most infiltrative, heterogenous types of brain
malignancies and is mainly associated with poor prognosis. Despite various advances in …

Glioblastoma (GBM) is one of the most aggressive and lethal malignancy of the central
nervous system. Temozolomide is the standard of care for gliomas, frequently results in …

Glioblastoma is the most common primary malignant brain neoplasm and it remains one of
the most difficult-to-treat human cancers despite decades of discovery and translational and …

Glioblastoma (GBM) is the most commonly diagnosed and most lethal primary malignant
brain tumor in adults. Standard treatments are ineffective, and despite promising results …